Description

This issue of Vital Signs, released on February 19, 2007, provides a strategic overview of the importance of healthcare industry collaboration for biomarker identification and clinical use. Additionally, an emerging company profile is provided for BioMarker Pharmaceuticals, a company focused on exploiting genetic differences to combat aging and obesity-related diseases. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of February 5 - February 9, 2007.